|
US2006115849A1
|
|
Screening methods
|
|
EP1737452A1
|
|
Angiogenesis-affecting compounds and methods of use thereof
|
|
CN1910199A
|
|
Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use
|
|
EP1699818A2
|
|
Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use
|
|
US2009036362A1
|
|
Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof
|
|
WO2005008250A1
|
|
Compounds and methods for promoting angiogenesis by using a gamma-secretase inhibitor or inhibiting the gamma-secretase pathway
|
|
WO03094610A1
|
|
Research models for the evaluation of retinopathy or microangiopathy and uses thereof
|
|
AU2003224575A1
|
|
Isolation of target cells, capillaries and microorgans
|
|
AU2003208684A1
|
|
Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto
|
|
US7396922B2
|
|
Regulation of hypoxia-inducible gene expression with antisense Inhibitory PAS domain protein
|
|
EP1353946A2
|
|
Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
|
|
US7214770B2
|
|
Screening Methods
|
